The concentration of IL-32 (protein) was determined in homogenates of patient-matched tumor and non-cancerous tumor-adjacent tissue (63 pairs) from 17 ESCC patients, 12 GC patients and 34 CRC patients using dedicated immunoassays. The gene discussed is IL32; the disease is neoplasm.